Inspire Investing LLC Makes New Investment in Oscar Health, Inc. $OSCR

Key Points

• Inspire Investing acquired 94,466 Oscar Health shares in the third quarter, valued at approximately $2.9 million. Institutional investors collectively own 75.7% of the company.
• Analyst sentiment remains mixed, with Oscar Health carrying a consensus “Hold” rating and an average price target of $34.90. Ratings range from Strong Buy to Sell.
• Oscar Health reported quarterly EPS of $1.10, exceeding estimates of $0.40, while revenue rose 70.4% year over year to $4.88 billion. The stock opened at $30.99, down 7.0%, and insiders have sold roughly $26.8 million in shares over the past 90 days.

Inspire Investing LLC bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 94,466 shares of the company's stock, valued at approximately $2,913,000.

Other hedge funds have also modified their holdings of the company. Tidal Investments LLC acquired a new stake in Oscar Health during the 2nd quarter worth about $2,240,000. Convergence Investment Partners LLC purchased a new stake in Oscar Health during the first quarter valued at about $1,208,000. Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new stake in Oscar Health during the first quarter valued at about $1,297,000. Wellington Management Group LLP boosted its holdings in shares of Oscar Health by 65.6% in the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock worth $17,217,000 after buying an additional 239,109 shares during the period. Finally, Genesee Capital Advisors LLC boosted its holdings in shares of Oscar Health by 227.8% in the third quarter. Genesee Capital Advisors LLC now owns 44,338 shares of the company's stock worth $1,367,000 after buying an additional 30,814 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on OSCR. The Goldman Sachs Group reissued a "neutral" rating and issued a $34.00 target price on shares of Oscar Health in a research report on Thursday, September 17th. Weiss Ratings upgraded shares of Oscar Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. Zacks Research raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 6th. Stephens reaffirmed an "equal weight" rating and issued a $34.00 price objective on shares of Oscar Health in a research note on Thursday, September 17th. Finally, Bank of America lifted their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the stock an "underperform" rating in a research report on Thursday, September 17th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Oscar Health currently has a consensus rating of "Hold" and an average target price of $34.90.

Insider Buying and Selling

In other news, insider Adam Mcananey sold 9,092 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $285,943.40. Following the completion of the sale, the insider directly owned 209,004 shares of the company's stock, valued at $6,573,175.80. This represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 10,360 shares of the firm's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the sale, the insider owned 248,697 shares of the company's stock, valued at approximately $7,821,520.65. This represents a 4.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock worth $26,761,671 over the last ninety days. 22.64% of the stock is currently owned by corporate insiders.

Oscar Health Stock Down 7.0%

NYSE:OSCR opened at $30.99 on Friday. The business's fifty day moving average price is $31.78 and its 200 day moving average price is $27.35. The firm has a market capitalization of $9.56 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 0.34 and a beta of 2.47. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $35.01.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same period last year, the company posted ($0.89) EPS. The business's quarterly revenue was up 70.4% compared to the same quarter last year. On average, sell-side analysts forecast that Oscar Health, Inc. will post 1.83 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act's health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.